ClinicalTrials.govpublic full text
Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin
obstructive sleep apnea syndrome, statins, cardiovascular risk, obstructive sleep apnea syndrome (osas) patients, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 857586
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.